The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1653
June 27, 2022
View Complete Issue         Table of Contents 2019 
Drugs for Sexually Transmitted Infections
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Sexually Transmitted Infections
June 27, 2022 (Issue: 1653)
This article includes recommendations for management of most sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages recommended here have not been approved by the FDA (see Table 1).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Sexually Transmitted Infections
Article code: 1653a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.